Use of proteasome inhibitors e.g. for the elimination of durable plasma cells, and for treating diseases that are associated with pathogenic antibodies, e.g. systemic lupus erythematosus, autoimmune hemolytic anemia and immune thrombopenia

摘要

Use of proteasome inhibitors for the elimination of durable plasma cells, is claimed. ACTIVITY : Antiinflammatory; Dermatological; Immunosuppressive; Antianemic; Hemostatic; Muscular-Gen.; Neuroprotective. MECHANISM OF ACTION : Proteasome inhibitor.